Reference
- Grantham J J, Burg MB. Effect of vasopressin and cyclic AMP on permeability of isolated collecting tubules. Am J Physiol 1966; 211: 255–9
- Hems D A, Whitton PD. Stimulation by vasopressin of glycogen breakdown and glucogeneogenesis in the perfused rat liver. Biochem J 1973; 136: 705–9
- Saameli K. The circulatory actions of the neurohypophysial hormones and similar polypeptides. Neurohypophysial hormones and similar polypeptides. Handbook of Experimental Pharmacology, B Berde. Springer-Verlag, Berlin, New York 1968; 545–612
- Tanaka M, de Kloet E R, De Wied D, Versteeg D HG. Arginine-vasopressin affects catecholamine metabolism in specific brain nuclei. Life Sci 1977; 20: 1799–803
- Mori N, Ohta K, Matsunaga T. The effect of vasopressin upon the cochlear potentials in the guinea pig. Acta Otolaryngol (Stockh) 1986; 101: 217–23
- Jard S. Vasopressin isoreceptors in mammals: relation to cyclic AMP-dependent and cyclic AMP-independent transduction mechanisms. Curr Top Membr Trans 1983; 18: 255–85
- Sawyer W H, Acosta M, Manning M. Structural changes in the arginine vasopressin molecule that prolong its antidiuretic action. Endocrinology 1974; 95: 140–9
- Kruszynski M, Lammek B, Manning M, Seto J, Haldar J, Sawyer WH. [1-(β-mercapto-β, β-cyclo-pentamethylenepropionic acid), 2-(0-methyl) tyrosine] arginine-vasopressin and [1-(β-mercapto-β-cyclopentamethylenepropionic acid)] arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin. J Med Chem 1980; 23: 364–8
- Konishi T, Hamrich PE. Ion transport in the cochlea of the guinea pig. I. Potassium and sodium transport. Acta Otolaryngol (Stockh) 1978; 86: 22–34
- Chase L R, Aurbach GD. Renal adenylate cyclase: Anatomically separate sites for parathyroid hormone and vasopressin. Science 1968; 159: 545–7
- Manning M, Nawrocka E, Misicka A., et al. Potent and selective antagonists of the antidiuretic responses to arginine-vasopressin based on modifications of [1-(β-Mercapto-β, β-pentamethylene-propionic acid), 2-D-isoleucine, 4-valine] arginine-vasopressin at position 4. J Med Chem 1984; 27: 423–9
- Grzonka Z, Kasprzykowski F, Kojro E., et al. Arginine-vasopressin analogues with high antidiuretic/vasopressor selectivity. Synthesis, biological activity, and receptor binding affinity of arginine-vasopressin analogues with substitutions in positions 1, 2, 4, 7, and 8. J Med Chem 1986; 29: 96–9
- Zenner H P, Zenner B. Vasopressin and isoproterenol activate adenylate cyclase in the guinea pig inner ear. Arch Otol Rhinol Laryngol 1979; 222: 275–83
- Schacht J. Hormonal regulation of adenylate cyclase in the stria vascularis of the mouse. Hear Res 1985; 20: 9–13
- Paloheimo S, Thalmann R. Influence of loop diuretics upon Na K-ATPase and adenylate cyclase of the stria vascularis. Arch Otol Rhinol Laryngol 1977; 217: 347–59
- Bagger-Sjöbäck D, Filipek C S, Schacht J. Characteristics and drug responses of cochlear and vestibular adenylate cyclase. Arch Otol Rhinol Laryngol 1980; 228: 217–22
- Schacht J. Adenylate cyclase and cochlear fluid. Am J Otol 1982; 3: 328–31
- Mees K. Cytochemical localization of adenylcyclase in the lateral wall of the inner ear. Arch Otol Rhinol Laryngol 1984; 240: 55–61
- Shugyo A, Mori N, Matsunaga T. The change in K+ activity of the scala media produced by vasopressin. Audiology (Japan) 1986; 29: 457–8
- Mori N, Ohya R, Shugyo A, Matsunaga T. The change in the electrical resistance of the scala media produced by vasopressin. Acta Otolaryngol (Stockh) 1987; 104: 66–70